But here’s some other pretty cool R&D (though not oncological), which might do in the meantime:
https://www.timesofisrael.com/uk-firm-buys-israeli-maker-of-algae-mimicking-medical-adhesives/

Dr. Judah Folkmann had a flash of insight into something very obvious, that all tissues require vascular perfusion, whether normal, benign or malignant. I remember how obvious his observation was when he first announced his thought, and felt it full of promise.

The know-nothings like “om” suck, a term which I do not use lightly.

There are only two ailments of man which can be (sometimes, sometimes not) cured: cancers and infectious diseases. Curing a cancer is a wonderful thing, emotionally, especially when that cancer is not a mere Stage I. And relieving suffering plus extending life is no small deal.

It sure beats the satisfactional hell out of whatever “om” does for a living. He likely preys on others, perhaps by “giving” (Hah!) advice in legal or financial realms. He might be a trial lawyer, an ambulance-chaser in the old parlance. Or a retail stockbroker who merely repeats what he has been told by his superiors, for a commission. Or, worst, he is an academic who cannot think straight, nor teach.

Mike K: your surgery prof in 1965 was an ass. There were fewer than 400 radiation oncologists in the entire USA then, and the few first-gen chemo agents were very toxic and generally ineffective. Surgeons did almost ALL the cancer work back then, and administered much of the chemo, so your prof. was indicting his own colleagues.
Medical oncology became a subspecialty Board with its first certifying exam in 1973. I passed it. But after two years of pouring chemo into patients, I bailed out because I couldn’t stand it any longer. I have to hand it to those who stood fast, developed the multi-drug protocols, and helped the new drugs like Adriamycin emerge.

I think there are about 13,000 oncologists in the United States, or about 2% of the licensed physicians herein. I don’t think that’s all that massive.

a) They use 3 targets — but there will still be times this isn’t enough
b) Like AIDS treatment, they use a “cocktail”; more likely to work on more folk, but still not all
c) hopefully few side effects; that’s part of what the human trials will show.

Thanks also to @sergey!

My professor of Surgery back in 1965 used to say “More people are living off cancer than dying from it.”